{"product_id":"cjc-1295-no-dac-ipamorelin-blend","title":"CJC-1295 (NO DAC) \/ IPAMORELIN BLEND","description":"\u003cp\u003eCJC-1295 (No DAC) is a growth hormone–releasing hormone (GHRH) analog, while Ipamorelin is a selective ghrelin (GHS-R1a) receptor agonist. When studied together, these peptides enable researchers to explore complementary GH-secretory pathways—GHRH receptor signaling and ghrelin receptor–mediated activation—within a unified experimental framework.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eComposition \u0026amp; Molecular Information\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis product contains two separate research compounds in a single vial:\u003c\/p\u003e\n\u003cp\u003eCJC-1295 (No DAC)\u003c\/p\u003e\n\u003cp\u003ePeptide Type: Synthetic GHRH (1–29) analog (No Drug Affinity Complex)\u003c\/p\u003e\n\u003cp\u003eMolecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂\u003c\/p\u003e\n\u003cp\u003eResearch Context: GHRH receptor agonism in pituitary and endocrine signaling models\u003c\/p\u003e\n\u003cp\u003eIpamorelin\u003c\/p\u003e\n\u003cp\u003ePeptide Type: Synthetic pentapeptide ghrelin receptor agonist\u003c\/p\u003e\n\u003cp\u003eMolecular Formula: C₃₈H₄₉N₉O₅\u003c\/p\u003e\n\u003cp\u003eResearch Context: Selective GHS-R1a receptor activation in GH-axis studies\u003c\/p\u003e\n\u003cp\u003eProduct Specifications\u003c\/p\u003e\n\u003cp\u003eTotal Content: 10 mg total peptide (5 mg CJC-1295 No DAC \/ 5 mg Ipamorelin)\u003c\/p\u003e\n\u003cp\u003eForm: Sterile, lyophilized powder (white to off-white)\u003c\/p\u003e\n\u003cp\u003ePurity: Research grade (typically ≥ 98% HPLC-verified per peptide)\u003c\/p\u003e\n\u003cp\u003eSolubility: Soluble in sterile water or compatible laboratory buffers\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eScientific \u0026amp; Research Relevance\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis dual-peptide blend supports simultaneous investigation of two primary GH-regulatory pathways:\u003c\/p\u003e\n\u003cp\u003eCJC-1295 (No DAC) activates the GHRH receptor, stimulating GH release through physiologic pituitary signaling pathways without long-acting plasma binding.\u003c\/p\u003e\n\u003cp\u003eIpamorelin activates the ghrelin (growth hormone secretagogue) receptor, offering a mechanistically distinct, non-GHRH route for GH-axis modulation.\u003c\/p\u003e\n\u003cp\u003eStudying both peptides together allows researchers to examine:\u003c\/p\u003e\n\u003cp\u003eSynergistic or additive endocrine signaling effects\u003c\/p\u003e\n\u003cp\u003eReceptor-specific versus dual-pathway GH regulation\u003c\/p\u003e\n\u003cp\u003eComparative kinetics of GHRH and ghrelin receptor activation\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTypical Research Applications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis blend is commonly utilized in laboratory and preclinical research for:\u003c\/p\u003e\n\u003cp\u003eGrowth hormone axis \u0026amp; pituitary signaling studies\u003c\/p\u003e\n\u003cp\u003eEndocrine receptor pharmacology and pathway analysis\u003c\/p\u003e\n\u003cp\u003eMetabolic and hormonal regulation research models\u003c\/p\u003e\n\u003cp\u003ePeptide synergy and receptor-interaction studies\u003c\/p\u003e\n\u003cp\u003eBenchmarking GH secretagogues in comparative assays\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy Researchers Choose This Blend\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCombines two complementary GH-pathway peptides in a single, defined formulation\u003c\/p\u003e\n\u003cp\u003eFeatures well-characterized molecular structures that support reproducibility\u003c\/p\u003e\n\u003cp\u003eNo DAC design allows investigation of short-acting GHRH analog dynamics\u003c\/p\u003e\n\u003cp\u003eHigh-purity, lyophilized research grade supports controlled experimental dosing\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRegulatory \/ Compliance Notice\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFOR RESEARCH USE ONLY.\u003cbr\u003eNot for human or veterinary use, diagnostic, therapeutic, or cosmetic applications.\u003cbr\u003eThis product has not been evaluated or approved by the U.S. Food and Drug Administration (FDA) or any regulatory authority.\u003cbr\u003eUse is strictly limited to in vitro, ex vivo, or preclinical research conducted under appropriate institutional and regulatory oversight.\u003c\/p\u003e","brand":"My Store","offers":[{"title":"5mg \/ 5mg","offer_id":50846609768763,"sku":null,"price":88.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0934\/3782\/1243\/files\/cjc-blend34934.jpg?v=1765815995","url":"https:\/\/nextlevellabs.org\/products\/cjc-1295-no-dac-ipamorelin-blend","provider":"Next Level Labs","version":"1.0","type":"link"}